Efficiency of Immunonutrition in Surgical Cancer Patients

The enteral diet enriched with arginine, glutamine, omega-3 fatty acids and nucleotides named as immunonutrition reduce the duration of hospital stay after surgery, infectious complications and the risk of morbidity. These nutrients modulate inflammatory response, intestinal and immunological functi...

Full description

Saved in:
Bibliographic Details
Main Authors: Pelin Polat (Author), M. Merve Tengillimoğlu Metin (Author), Mevlüde Kızıl (Author)
Format: Book
Published: Hacettepe University, 2019-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a6826a9ddd0e456c8bb5e0c3cdd1323f
042 |a dc 
100 1 0 |a Pelin Polat   |e author 
700 1 0 |a M. Merve Tengillimoğlu Metin  |e author 
700 1 0 |a Mevlüde Kızıl  |e author 
245 0 0 |a Efficiency of Immunonutrition in Surgical Cancer Patients 
260 |b Hacettepe University,   |c 2019-03-01T00:00:00Z. 
500 |a 2528-9918 
520 |a The enteral diet enriched with arginine, glutamine, omega-3 fatty acids and nucleotides named as immunonutrition reduce the duration of hospital stay after surgery, infectious complications and the risk of morbidity. These nutrients modulate inflammatory response, intestinal and immunological functions. The immune system is the primary defense against pathogenic microorganisms and cancer cells. The release of proinflammatory cytokines, the formation of reactive oxygen nitrogen species are required for the inflammatory response. Regulation of the immune system with dietary components has become as an important additional therapy in cancer patients. Although there are randomized controlled trials showing positive effects of immunonutrients in serious diseases such as trauma or burn, there is no strong evidence for these effects in cancer patients. Further prospective studies are needed to demonstrate beneficial effects of immunonutrition in cancer patients. In this review, studies evaluating the efficacy of immunonutrition in cancer patients are summarized. 
546 |a EN 
546 |a TR 
690 |a immunonutrient 
690 |a immunonutrition 
690 |a cancer 
690 |a Other systems of medicine 
690 |a RZ201-999 
690 |a Miscellaneous systems and treatments 
690 |a RZ409.7-999 
690 |a Nutritional diseases. Deficiency diseases 
690 |a RC620-627 
655 7 |a article  |2 local 
786 0 |n Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Vol 3, Iss 3, Pp 1-16 (2019) 
787 0 |n https://dergipark.org.tr/tr/download/article-file/324280 
787 0 |n https://doaj.org/toc/2528-9918 
856 4 1 |u https://doaj.org/article/a6826a9ddd0e456c8bb5e0c3cdd1323f  |z Connect to this object online.